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Saint Louis encephalitis (SLE) is a mosquitoborne disease caused by a member of the Flaviviridae family. Less than 1% of SLE viral infections are clinically apparent. Poor prognosis is associated with advanced age, and with higher frequency of meningoencephalitis. 1 Although it has been responsible for several outbreaks in the general population, there has been few reports on HIV patients. 2, 3 he potential impact of HIV-1 induced immune deiciency over the SLE clinical course remains unclear. In Argentina, despite of a seroprevalence ranging from 3% to 50%, 4, 5 only two outbreaks of SLE have been reported. 6, 7 Herein we describe two cases of meningoencephalitis caused by SLE virus in HIV-1-infected patients from Buenos Aires.
On late summer 2010, a 30-year-old man was seen at the emergency room because of fever and altered mental status. He had been diagnosed with HIV infection since 2007. He had never received antiretroviral therapy (HAART). He lived in Buenos Aires and had not travelled in the last year. here was no history of exposure to animals or contact with ill people. On admission he was disoriented and lethargic. Neck stifness without focal neurologic signs was found. Laboratory indings were not remarkable. CD4+ cell count was 423 cells/mm 3 . Computed tomographic scan of the brain was normal. Lumbar puncture showed mild mononuclear pleocytosis. PCR testing in cerebral spinal luid (CSF) for HSV, enterovirus, and cytomegalovirus were negative. hree days later, the patient remained febrile and meningeal signs had progressed. He became more lethargic, with incomprehensible speech and myoclonies. A magnetic resonance imaging (MRI) of the brain with gadolinium and an electroencephalogram showed no abnormalities.
On the ith day, the patient clinical picture began to improve. He was discharged on the twelth day with resolved clinical symptoms, totally oriented; only acute memory disturbances persisted.
One month later, a 44 year-old male patient was admitted with headache and confusion. HIV-1 infection had been diagnosed ive months before. His baseline CD4 was 500 cells/mm 3 (24%). No HAART was started. His medical record was unremarkable. On admission, he was febrile and confuse, with mild somnolence and occipital headache. Laboratory indings were unremarkable; CD4+ cell count was 402 cells/mm 3 . A lumbar puncture was performed with mild leucocytosis (mononuclear cells). Electroencephalogram showed difuse abnormal slow rhythm. On the fourth day, the patient developed transient aphasia, and a confusional syndrome became more evident. MRI with gadolinium revealed increased T2 and FLAIR signal involving both temporal lobes. PCR for enterovirus, HZV and HSV were negative at CSF. Mental status improved progressively, and fever disappeared. He was discharged on the twelfth d a y f u l l y r e covered.
Este é um artigo Open Access sob a licença de CC BY-NC-ND Serum and CSF to determine SLE IgM antibodies were positive by MAC ELISA in both patients. We also performed neutralization tests (NT) in paired samples of serum for SLE to confirm diagnosis. Because of serologic cross reactions with other closely related flavivirus circulating in our country, NT were also performed against dengue and West Nile viruses. Both results were negative. Ink smear, Ziehl-Nielsen and Gram staining in CSF were negative. Fungal, bacterial, and mycobacterial CSF and blood cultures showed no growth.
To the best of our knowledge, this is the first report of SLE in patients with HIV infection in Buenos Aires, Argentina. The clinical course was benign with mild memory disturbances. It is important to highlight that SLE virus is an emerging pathogen with potential to spread rapidly, and should be considered in the differential diagnosis of CNS disease in HIV-infected patients living in Buenos Aires.
